Eyestem Research Pvt.
Latest round
- Series A
Last raised
- Aug 2022
Total raised
- $6.4M
Investors
- 5
About Eyestem Research Pvt.
Eyestem Research Pvt. Ltd.Founded in 2016 in Bangalore, India, Eyestem Research Pvt. Ltd. focuses on developing transformative cell therapies. The company is co-founded by Jogin Desai, who has extensive experience in the biotech sector.Eyestem specializes in developing scalable cell replacement therapies, with its lead product, Eyecyte-RPE™, aimed at treating Dry Age-related Macular Degeneration (AMD). This condition affects about 170 million people worldwide, especially those over 60. Eyestem’s products are currently undergoing pivotal efficacy and safety studies at Oregon Health and Science University, with plans for first-in-man studies in 2024.1 million and an EBITDA of INR -1,819,360 million. The company is focused on launching Eyecyte-RPE™ and aims to expand its presence into new markets, particularly in North America and Europe, by 2025.
Who invested in Eyestem Research Pvt.
5 investors across 1 round
See all investors in Eyestem Research Pvt.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 8, 2022
Amount
$6.4M
Investors
Questions about Eyestem Research Pvt.
Who invested in Eyestem Research Pvt.?
Eyestem Research Pvt. has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eyestem Research Pvt. raised?
Eyestem Research Pvt. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Eyestem Research Pvt. last raise money?
Eyestem Research Pvt.'s most recent round on record is a Series A, in Aug 2022.
What does Eyestem Research Pvt. do?
Eyestem Research Pvt. is a biotechnology company.
Where is Eyestem Research Pvt. headquartered?
Eyestem Research Pvt. is headquartered in Bangalore, India.
Which VCs invest in companies like Eyestem Research Pvt.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Eyestem Research Pvt.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Eyestem Research Pvt.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.